Dexmedetomidine protects against glucocorticoid induced progenitor cell apoptosis in neonatal mouse cerebellum

References

• Barton L, Hodgman JE, Pavlova Z. Causes of death in the extremely low birth weight infant. Pediatrics 1999;103:446–51
   PubMed Web of Science ®Google Scholar
• Patel RM, Kandefer S, Walsh MC, et al. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med 2015;372:331–40
   PubMed Web of Science ®Google Scholar
• Halliday HL, Ehrenkranz RA, Doyle LW. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2000;CD001144
   PubMedGoogle Scholar
• Yeh TF. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. New Engl J Med 2004;350:1304–13
   PubMed Web of Science ®Google Scholar
• Parikh NA, Lasky RE, Kennedy KA, et al. Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infants. Pediatrics 2007;119:265–72
   PubMed Web of Science ®Google Scholar
• Tam EW, Chau V, Ferriero DM, et al. Preterm cerebellar growth impairment after postnatal exposure to glucocorticoids. Sci Transl Med 2011;3:105ra
   Web of Science ®Google Scholar
• Cheong JL, Burnett AC, Lee KJ, et al. Association between postnatal dexamethasone for treatment of bronchopulmonary dysplasia and brain volumes at adolescence in infants born very preterm. J Pediatr 2014;164:737–43
   PubMed Web of Science ®Google Scholar
• Noguchi KK, Lau K, Smith DJ, et al. Glucocorticoid receptor stimulation and the regulation of neonatal cerebellar neural progenitor cell apoptosis. Neurobiol Dis 2011;43:356–63
   PubMed Web of Science ®Google Scholar
• Noguchi KK, Walls KC, Wozniak DF, et al. Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death. Cell Death Differ 2008;15:1582–92
   PubMed Web of Science ®Google Scholar
• Carletti B, Rossi F. Neurogenesis in the cerebellum. Neuroscientist 2008;14:91–100
   PubMed Web of Science ®Google Scholar
• Bohn MC, Lauder JM. The effects of neonatal hydrocortisone on rat cerebellar development. Dev Neurosci 1978;1:250–66
   Web of Science ®Google Scholar
• Maloney SE, Noguchi KK, Wozniak DF, et al. Long-term effects of multiple glucocorticoid exposures in neonatal mice. Behav Sci (Basel) 2011;1:4–30
   PubMedGoogle Scholar
• Cabrera O, Dougherty J, Singh S, et al. Lithium protects against glucocorticoid induced neural progenitor cell apoptosis in the developing cerebellum. Brain Res 2014;1545:54–63
   PubMed Web of Science ®Google Scholar
• Siddappa R, Riggins J, Kariyanna S, et al. High-dose dexmedetomidine sedation for pediatric MRI. Paediatr Anaesth 2011;21:153–8
   PubMed Web of Science ®Google Scholar
• Chrysostomou C, Schulman SR, Herrera Castellanos M, et al. A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr 2014;164:276–82 e1–3
   PubMed Web of Science ®Google Scholar
• O'Mara K, Gal P, Wimmer J, et al. Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates. J Pediatr Pharmacol Ther 2012;17:252–62
   PubMedGoogle Scholar
• Wagner DS, Brummett CM. Dexmedetomidine: as safe as safe can be. Semin Anesth Perioperat Med Pain 2006;25:77–83
   Google Scholar
• Sanders RD, Sun P, Patel S, et al. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand 2010;54:710–16
   PubMed Web of Science ®Google Scholar
• Sanders RD, Xu J, Shu Y, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology 2009;110:1077–85
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao B, Li X. Dexmedetomidine attuenuates isoflurane-induced cognitive impairment through antioxidant, anti-inflammatory and anti-apoptosis in aging rat. Int J Clin Exp Med 2015;8:17281–8
   PubMed Web of Science ®Google Scholar
• Zhu YM, Wang CC, Chen L, et al. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Brain Res 2013;1494:1–8
   PubMed Web of Science ®Google Scholar
• Schoeler M, Loetscher PD, Rossaint R, et al. Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury. BMC Neurol 2012;12:20
   PubMed Web of Science ®Google Scholar
• Dougherty JD, Garcia AD, Nakano I, et al. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase. J Neurosci 2005;25:10773–85
   PubMed Web of Science ®Google Scholar
• Heine VM, Rowitch DH. Hedgehog signaling has a protective effect in glucocorticoid-induced mouse neonatal brain injury through an 11betaHSD2-dependent mechanism. J Clin Invest 2009;119:267–77
   PubMed Web of Science ®Google Scholar
• McPherson C, Grunau RE. Neonatal pain control and neurologic effects of anesthetics and sedatives in preterm infants. Clin Perinatol 2014;41:209–27
   PubMed Web of Science ®Google Scholar
• Chandler DJ, Nicholson SE, Zitnik G, Waterhouse BD. Norepinephrine and synaptic transmission in the cerebellum. In: Manto M, Gruol DL, Schmahmann J, et al., eds. Handbook of the cerebellum and cerebellar disorders. Dordrecht, Netherlands: Springer; 2013;895–914
   Google Scholar
• Happe HK, Coulter CL, Gerety ME, et al. Alpha-2 adrenergic receptor development in rat CNS: an autoradiographic study. Neuroscience 2004;123:167–78
   PubMed Web of Science ®Google Scholar
• Slotkin TA, Lappi SE, McCook EC, et al. Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity. Biol Neonate 1992;61:326–36
   PubMedGoogle Scholar
• Li Y, Zeng M, Chen W, et al. Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K/Akt pathway in the hippocampus of neonatal rats. PLoS One 2014;9:e93639
   PubMed Web of Science ®Google Scholar